FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis
The biosimilar has also been approved for Crohn’s disease, ulcerative colitis, and ankylosing spondylitis.
Crohn Disease
Benefit of fiber intake not equal in IBD patients
Patients with Crohn disease who ate high-fiber foods were 40% less likely to have a disease flare.
Crohn disease: diagnosis and treatment
A condition prone to recurrence, Crohn disease has a complicated presentation and pathophysiology, but multiple treatment options are available.
Non-TNF blocker for colitis, Crohn disease
Entyvio can be used to treat ulcerative colitis and Crohn disease in adults who did not have success with other treatments.
Asthma, COPD linked with more inflammatory bowel disease
People with airway diseases are more likely to have inflammatory bowel disease.
Vedolizumab approved to treat ulcerative colitis, Crohn disease
The FDA has approved vedolizumab for patients with inadequate response to conventional therapies.
Help for kids with new Crohn’s disease
Early monotherapy with such anti-TNF-alpha agents as infliximabor and adalimumab may produce better overall clinical and growth outcomes.
High fiber intake reduces Crohn’s disease risk
Greatest reductions observed for fiber derived from fruits.
Thalidomide improves Crohn’s remission in kids
Once-daily thalidomide improved clinical remission at eight weeks for children with refractory Crohn’s disease
Adalimumab effective for pediatric Crohn’s disease
Adalimumab induction and maintenance was shown to be safe and effective for children with moderate-to-severe Crohn’s.
- Loading...
Loading...
Next post in Web Exclusives
Loading... 
Loading...